SCHEMBL7680475

SCHEMBL7680475

COc1nc2cc(Cl)c(Cl)c(-c3ncnn3C)c2nc1OC

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.36
BDKRB2 P30411 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27411178 0.83 BDKRB2 (0.33) HRH4BDKRB2
SCHEMBL7681496 0.81 SMN1; SMN2 (0.43) HRH4
SCHEMBL7676533 0.77 HRH4 (0.36) HRH4BDKRB2
SCHEMBL7676249 0.75 HRH4 (0.36) HRH4
SCHEMBL7473964 0.73 HRH4 (0.39) HRH4
SCHEMBL7678718 0.72 CYP1A2 (0.37) HRH4
SCHEMBL7824628 0.72 P2RX7 (0.33) HRH4
SCHEMBL7676130 0.70 MAPT (0.40)
SCHEMBL7673287 0.69 RAB9A (0.49) HRH4
SCHEMBL16583445 0.69 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed